Cross-IMI project Symposium at Alzheimer Europe Conference (MOPEAD, EPAD & ROADMAP)

Leaflet of the speacial symposium at Alzheimer Europe’s 27th Conference in Berlin: “Engaging with patient organisations within IMI consortia to inform quality, relevance and value in Alzheimer’s research – insights from MOPEAD, EPAD and ROADMAP”.

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 116020 (“ROADMAP”). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Contact, Legal Notice & Privacy Policy